Chronic Thromboembolic Disease and Chronic Thromboembolic Pulmonary Hypertension
Iréne Lang, Ioana A. Campean, Roela Sadushi‐Kolici, R Badr-Eslam, Christian Gerges, Nika Skoro‐Sajer
Abstract
Chronic thromboembolic pulmonary hypertension (CTEPH) and chronic thromboembolic pulmonary vascular disease (CTED) are rare manifestations of venous thromboembolism. Presumably, CTEPH and CTED are variants of the same pathophysiological mechanism. CTEPH and CTED can be near-cured by pulmonary endarterectomy, balloon pulmonary angioplasty, and medical treatment with Riociguat or subcutaneous treprostinil, which are the approved drugs.
Topics & Concepts
MedicineChronic thromboembolic pulmonary hypertensionRiociguatTreprostinilPulmonary hypertensionThromboembolic diseaseAngioplastyCardiologyInternal medicinePulmonary diseaseBalloonIntensive care medicineThrombosisPulmonary Hypertension Research and TreatmentsVenous Thromboembolism Diagnosis and ManagementVascular Anomalies and Treatments